Hypothesis generation for rare and undiagnosed diseases through clustering and classifying time-versioned biological ontologies.
Where this comes from
- Record sourced from PubMed, PMID 39724242.
- Also identified by DOI 10.1371/journal.pone.0309205 and PMC identifier 11670971.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Rare diseases affect 1-in-10 people in the United States and despite increased genetic testing, up to half never receive a diagnosis. Even when using advanced genome sequencing platforms to discover variants, if there is no connection between the variants found in the patient's genome and their phenotypes in the literature, then the patient will remain undiagnosed. When a direct variant-phenotype connection is not known, putting a patient's information in the larger context of phenotype relationships and protein-protein interactions may provide an opportunity to find an indirect explanation. Databases such as STRING contain millions of protein-protein interactions, and the Human Phenotype Ontology (HPO) contains the relations of thousands of phenotypes. By integrating these networks and clustering the entities within, we can potentially discover latent gene-to-phenotype connections. The historical records for STRING and HPO provide a unique opportunity to create a network time series for evaluating the cluster significance. Most excitingly, working with Children's Hospital Colorado, we have provided promising hypotheses about latent gene-to-phenotype connections for 38 patients. We also provide potential answers for 14 patients listed on MyGene2. Clusters our tool finds significant harbor 2.35 to 8.72 times as many gene-to-phenotype edges inferred from known drug interactions than clusters found to be insignificant. Our tool, BOCC, is available as a web app and command line tool.
Medical subject headings
- Rare Diseases
- Biological Ontologies